Literature DB >> 7807183

Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients.

R Bashir1, B McManus, C Cunningham, D Weisenburger, F Hochberg.   

Abstract

Tissue from primary central nervous system lymphoma (PCNSL) which developed in five patients with acquired immuno deficiency syndrome (AIDS), nine patients without immunodeficiency, and two Epstein-Barr virus (EBV)-positive control cell lines (B95-8 and Raji) were examined for the presence of EBER-1 RNA. The tissues were hybridized with digoxigenin-labeled sense or anti-sense EBER-1 riboprobes. In all five AIDS-related PCNSLs, strong hybridization signals were found with the EBER-1 anti-sense probe. Signals could be eliminated by preincubation of the tissues with RNase-A. Hybridization with the EBER-1 sense probe showed no signal. All PCNSLs from immunocompetent patients (five paraffin-embedded, four frozen) showed no hybridization signals with EBER-1 sense or antisense probe but good hybridization signals with probes to immunoglobulin kappa or lambda light chain indicating RNA preservation. The paraffin-embedded B95-8-positive control cell-line showed positive hybridization in most cells with the anti-sense EBER-1 probe, and up to one percent of the cells had a weak signal with the sense probe. Most Raji cells showed a uniform signal with the anti-sense EBER-1 probe only. We conclude that, PCNSLs that arise in AIDS patients are associated with latent EBV infections, whereas PCNSLs from immunocompetent patients are not indicating a probable role for EBV in pathogenesis of these tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7807183     DOI: 10.1007/bf01057960

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

Review 1.  Acquired immunodeficiency syndrome-related lymphoma.

Authors:  A M Levine
Journal:  Blood       Date:  1992-07-01       Impact factor: 22.113

2.  Detection of Epstein-Barr virus sequences in primary brain lymphoma without immunodeficiency.

Authors:  Y J Bignon; P Clavelou; F Ramos; A Jouvet; M Tommasi; M Tournilhac; B Dastugue; R Plagne
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

3.  Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization.

Authors:  J G Howe; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Detection of Epstein-Barr virus in CNS lymphomas by in-situ hybridization.

Authors:  R M Bashir; N L Harris; F H Hochberg; R M Singer
Journal:  Neurology       Date:  1989-06       Impact factor: 9.910

5.  Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization.

Authors:  E Rouah; B B Rogers; D R Wilson; J B Kirkpatrick; G J Buffone
Journal:  Hum Pathol       Date:  1990-05       Impact factor: 3.466

6.  In situ hybridization for the detection of Epstein-Barr virus in central nervous system lymphomas.

Authors:  R E Nakhleh; J C Manivel; C M Copenhaver; J H Sung; J G Strickler
Journal:  Cancer       Date:  1991-01-15       Impact factor: 6.860

7.  Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study.

Authors:  Y T So; J H Beckstead; R L Davis
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

8.  Increasing incidence of primary brain lymphoma in the US.

Authors:  N L Eby; S Grufferman; C M Flannelly; S C Schold; F S Vogel; P C Burger
Journal:  Cancer       Date:  1988-12-01       Impact factor: 6.860

9.  Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain.

Authors:  R Bashir; H Coakham; F Hochberg
Journal:  J Neurooncol       Date:  1992-02       Impact factor: 4.130

10.  Selective acceptance of MHC class I-deficient tumor grafts in the brain.

Authors:  H G Ljunggren; T Yamasaki; P Collins; G Klein; K Kärre
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  5 in total

1.  Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; H Irene Hall; Jianmin Li; James J Goedert; Lindsay M Morton; Patricia Hartge; Eric A Engels
Journal:  JAMA       Date:  2011-04-13       Impact factor: 56.272

2.  Epstein-Barr virus and brain lymphomas.

Authors:  R M Bashir; F H Hochberg; M X Wei
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  The genomic and transcriptional landscape of primary central nervous system lymphoma.

Authors:  Josefine Radke; Naveed Ishaque; Randi Koll; Zuguang Gu; Elisa Schumann; Lina Sieverling; Sebastian Uhrig; Daniel Hübschmann; Umut H Toprak; Cristina López; Xavier Pastor Hostench; Simone Borgoni; Dilafruz Juraeva; Fabienne Pritsch; Nagarajan Paramasivam; Gnana Prakash Balasubramanian; Matthias Schlesner; Shashwat Sahay; Marc Weniger; Debora Pehl; Helena Radbruch; Anja Osterloh; Agnieszka Korfel; Martin Misch; Julia Onken; Katharina Faust; Peter Vajkoczy; Dag Moskopp; Yawen Wang; Andreas Jödicke; Lorenz Trümper; Ioannis Anagnostopoulos; Dido Lenze; Ralf Küppers; Michael Hummel; Clemens A Schmitt; Otmar D Wiestler; Stephan Wolf; Andreas Unterberg; Roland Eils; Christel Herold-Mende; Benedikt Brors; Reiner Siebert; Stefan Wiemann; Frank L Heppner
Journal:  Nat Commun       Date:  2022-05-10       Impact factor: 17.694

4.  Coexistence of primary central nervous system lymphoma and primary breast lymphoma: Clinical presentation, imaging features, and treatment management.

Authors:  Francesca Di Giuliano; Tommaso Perretta; Francesca Pitocchi; Noemi Pucci; Maria Lina Serio; Aurelia Caliandro; Eliseo Picchi; Valentina Ferrazzoli; Chiara Adriana Pistolese; Francesco Garaci; Roberto Floris
Journal:  Radiol Case Rep       Date:  2022-05-09

5.  Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.

Authors:  Eri Ishikawa; Seiichi Kato; Kazuyuki Shimada; Tsutomu Tanaka; Yuka Suzuki; Akira Satou; Kei Kohno; Ayako Sakakibara; Takeshi Yamamura; Masanao Nakamura; Ryoji Miyahara; Hidemi Goto; Shigeo Nakamura; Yoshiki Hirooka
Journal:  Cancer Med       Date:  2018-11-18       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.